MedTrace Logo

MuscleCare™ Pain Relief Therapy vs. Voltaren® in the Relief of Trapezius Trigger Point Musculoskeletal Pain.

NCT03939884 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2019-05-07

No results posted yet for this study

Summary

To determine the difference in efficacy of an all natural topical analgesic (MuscleCare) to a product containing the non-steroidal anti-inflammatory drug diclofenac (Voltaren) on trapezius trigger point pain.

Conditions

Interventions

DRUG

MuscleCare Topical Product

Application of the product will be applied with six circular applications over the trigger point and left to rest for 7 minutes.

DRUG

Voltaren Topical

Application of the product will be applied with six circular applications over the trigger point and left to rest for 7 minutes.

DRUG

Nivea, Topical Cream

Application of the product will be applied with six circular applications over the trigger point and left to rest for 7 minutes.

Sponsors & Collaborators

  • Active and Innovative Inc.

    collaborator OTHER

  • University of Toronto

    lead OTHER

Principal Investigators

  • Jack Goodman, PhD · University of Toronto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-28
Primary Completion
2018-02-25
Completion
2018-02-25

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03939884 on ClinicalTrials.gov